Global biometrics Phastar is a global biometrics and data science CRO with a clientele spanning pharma, biotech, and medical devices, presenting a broad cross-border selling opportunity for advanced analytics, regulatory support, and trial optimization services.

AI driven efficiency Their emphasis on AI-enhanced analytics and advanced statistical methods signals a selling point for agencies seeking faster data insights, accelerated regulatory submissions, and risk mitigation throughout clinical trials.

Lifecycle partnerships Phastar positions itself as a partner that turns complexity into clarity, offering scalable, tailored solutions that could be packaged as end-to-end trial data management, analytics, and consulting engagements.

Regulatory readiness With a focus on global standards compliance and accelerating approvals, there is a clear opportunity to pitch Phastar to sponsors aiming to streamline regulatory pathways and reduce submission timelines.

Mid-market potential Phastar’s revenue range and employee size indicate a fit for mid-sized to large trial programs; target similarly sized biotech and medtech clients seeking rigorous data science support without engaging large CROs.